Search Results

Your search for Syed A. Abutalib, MD, and Katharina Fleischhauer, MD,Syed A. Abutalib, MD, and Katharina Fleischhauer, MD matches 2 pages

Showing 1 - 2

By Syed A. Abutalib, MD, and Katharina Fleischhauer, MD / October 25, 2016

Donor Selection for HLA-Matched Hematopoietic Cell Transplantation

Question 1: Which statement about donor selection for allogeneic hematopoietic cell transplant is correct? Correct Answer: C. If a donor is available, the genotypic identity between the patient and his brother should be established by typing the patient’s parents; if this is not possible, the...

leukemia

By Syed A. Abutalib, MD, and Katharina Fleischhauer, MD / October 25, 2016

Donor Selection for HLA-Matched Hematopoietic Cell Transplantation

Case Study A 33-year-old white male is diagnosed with acute myeloid leukemia (AML) with complex cytogenetics. A decision is made in favor of performing allogeneic hematopoietic cell transplantation in first complete remission. The patient has a 35-year-old brother who is healthy and motivated to...

Jun

Today In Oncology

Search Results

Your search for Syed A. Abutalib, MD, and Katharina Fleischhauer, MD,Syed A. Abutalib, MD, and Katharina Fleischhauer, MD matches 2 pages

Donor Selection for HLA-Matched Hematopoietic Cell Transplantation

Donor Selection for HLA-Matched Hematopoietic Cell Transplantation

Vorasidenib Delays Disease Progression or Death in Patients With Grade 2 IDH-Mutated Glioma

Radiation May Be Safely Omitted in Select Patients With Locally Advanced Rectal Cancer

Adjuvant Osimertinib Improves Survival in Patients With Resected EGFR-Mutated NSCLC

Nivolumab May Reduce Risk of Disease Progression or Death in Previously Untreated Patients With Hodgkin Lymphoma Compared to Brentuximab Vedotin

Mirvetuximab Soravtansine Improves Survival in Patients With Recurrent Ovarian Cancer